Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does NINTEDANIB ESYLATE Cause Loss of consciousness? 10 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 10 reports of Loss of consciousness have been filed in association with NINTEDANIB ESYLATE (Ofev). This represents 8.6% of all adverse event reports for NINTEDANIB ESYLATE.

10
Reports of Loss of consciousness with NINTEDANIB ESYLATE
8.6%
of all NINTEDANIB ESYLATE reports
1
Deaths
10
Hospitalizations

How Dangerous Is Loss of consciousness From NINTEDANIB ESYLATE?

Of the 10 reports, 1 (10.0%) resulted in death, 10 (100.0%) required hospitalization, and 8 (80.0%) were considered life-threatening.

Is Loss of consciousness Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for NINTEDANIB ESYLATE. However, 10 reports have been filed with the FAERS database.

What Other Side Effects Does NINTEDANIB ESYLATE Cause?

Diarrhoea (54) Nausea (24) Decreased appetite (20) Fatigue (20) Vomiting (20) Dyspnoea (18) Weight decreased (17) Off label use (16) Constipation (13) Dizziness (13)

What Other Drugs Cause Loss of consciousness?

ADALIMUMAB (4,431) QUETIAPINE (1,483) PREGABALIN (1,463) OXYCODONE (1,424) METHOTREXATE (1,294) LENALIDOMIDE (1,281) ETANERCEPT (1,237) TREPROSTINIL (1,196) TRAMADOL (1,154) INFLIXIMAB (1,150)

Which NINTEDANIB ESYLATE Alternatives Have Lower Loss of consciousness Risk?

NINTEDANIB ESYLATE vs NIRAPARIB NINTEDANIB ESYLATE vs NIRMATRELVIR\RITONAVIR NINTEDANIB ESYLATE vs NIROGACESTAT NINTEDANIB ESYLATE vs NIROGACESTAT HYDROBROMIDE NINTEDANIB ESYLATE vs NIRSEVIMAB

Related Pages

NINTEDANIB ESYLATE Full Profile All Loss of consciousness Reports All Drugs Causing Loss of consciousness NINTEDANIB ESYLATE Demographics